Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07588607 · ClinicalTrials.gov registry record · NA

Social Media Posts About Cancer: Five Timepoints

A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
294
Enrollment target

NCT07588607: Completed NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.

NCT07588607 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 294 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07588607, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
294 participants
Enrollment target

Study Summary

The main purpose of this trial was to evaluate the impact of user interface designs on intervening with cancer misinformation on social media. The investigators conducted a randomized clinical trial with a sample of 294 US adults (ages 18-65) who previously had a cancer diagnosis or were a cancer caregiver. This registration record only covers the 5 timepoint trial under the same IRB number.

Primary Outcome

Measured with intervening behavior, defined as the flag icon selected. Response options were no (coded as 0) or yes (coded as 1). Assessed 15 times. Assessed for 2 cancer misinformation posts and 1 cancer support post at each timepoint approximately 2 business days apart, starting on the day of enrollment.

Interventions

  • BEHAVIORAL Social cue prompt and policy
  • BEHAVIORAL Standard prompts

Trial Details

FieldValue
Enrollment Target 294 participants
Start Date 2025-03-31
Est. Completion 2025-05-12
Phase NA

What the finished NCT07588607 record still lists

NCT07588607 is an interventional study that assigns participants to a tested intervention. The registered 294 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 2 interventions - of which Social cue prompt and policy is the first listed.

NCT07588607 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07588607 about?

NCT07588607 is a clinical study titled "Social Media Posts About Cancer: Five Timepoints". The main purpose of this trial was to evaluate the impact of user interface designs on intervening with cancer misinformation on social media. The investigators conducted a randomized clinical trial with a sample of 294 US adults (ages 18-65) who previously had a cancer diagnosis or were a cancer ca...

What is the current status of trial NCT07588607?

This trial is currently completed. It is a NA study. The enrollment target is 294 participants. The study started on 2025-03-31. Estimated completion is 2025-05-12.

What interventions are being tested in trial NCT07588607?

The interventions under investigation include: Social cue prompt and policy (BEHAVIORAL), Standard prompts (BEHAVIORAL).

Who is sponsoring clinical trial NCT07588607?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07588607's enrollment target sits among peer trials

294 373rd of 2000 higher than 1,626 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05775159 · 294 participants · Phase 2

    Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

  • NCT06262113 · 294 participants · NA

    A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1

  • NCT06338865 · 294 participants · NA

    Short Title: Standard vs. Lower Pressure Pneumoperitoneum

  • NCT06395467 · 294 participants · NA

    Integrated Treatment for Enhancing Growth in Recovery During Adolescence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07588607, the US trial registry maintained by the National Library of Medicine. NCT07588607 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.